» Articles » PMID: 36747483

Electrocardiogram Abnormalities and Renal Impairment in Patients with Type 2 Diabetes Mellitus: A Healthcare Facilities-based Cross-sectional Study in Dang District of Nepal

Abstract

Aims/introduction: The global burden of diabetes mellitus is rising substantially, with a further increase in cardiovascular and kidney disease burden. These public health problems are highly prevalent in low- and middle-income countries, including Nepal. However, there is limited evidence on cardiac and renal conditions among patients with type 2 diabetes mellitus. We determined the status of electrocardiogram (ECG) abnormalities and renal impairment among patients with type 2 diabetes mellitus in Nepal.

Methods: We carried out a cross-sectional study in Tulsipur Sub-Metropolitan City of Nepal using a multistage stratified sampling technique to recruit patients with type 2 diabetes mellitus. We used World Health Organization stepwise approach to surveillance (WHO STEPS) questionnaires and carried out resting ECG to collect data of 345 patients with type 2 diabetes mellitus. Logistic regression analysis assessed the factors associated with ECG abnormalities and renal impairment.

Results: The study showed that 6.1% of participants had major ECG abnormalities (95% confidence interval [CI] 3.8-8.6%), which were associated with hypertension (P = 0.01%) and low socioeconomic status (P = 0.01). The proportion of major and/or minor ECG abnormalities was 47.8% (95% CI 40.5-51%), and were significantly associated with age (odds ratio [OR] 1.04, 95% CI 1.01-1.07), higher education (OR 3.50, 95% CI 1.31-9.33), unemployment (OR 3.02, 95% CI 1.08-8.48), body mass index (OR 1.09, 95% CI 1.02-1.17) and duration of type 2 diabetes mellitus >5 years (OR 2.42, 95% CI 1.19-4.93). The proportion of renal impairment was 3.5% (95% CI 1.5-4.5%) which was associated with older age (OR 1.08, 95% CI 1.00-1.17) and hypertension (OR 12.12, 95% CI 1.07-138.22).

Conclusion: A significant proportion of patients with type 2 diabetes mellitus had ECG abnormalities and renal impairment, which were significantly associated with hypertension. Therefore, hypertension management and early screening are essential to prevent future cardiorenal complications among patients with type 2 diabetes mellitus.

Citing Articles

Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Hu Y, Liang Y, Li J, Li X, Yu M, Cui W Cardiovasc Diabetol. 2025; 24(1):40.

PMID: 39856691 PMC: 11763136. DOI: 10.1186/s12933-025-02593-z.

References
1.
Singh N, Ingle G, Saini V, Jami A, Beniwal P, Lal M . Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and Modification of Diet in Renal Disease equation: an observational, cross-sectional study. BMC Nephrol. 2009; 10:4. PMC: 2663556. DOI: 10.1186/1471-2369-10-4. View

2.
Gyawali B, Hansen M, Povlsen M, Neupane D, Andersen P, McLachlan C . Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial. PLoS One. 2018; 13(11):e0206491. PMC: 6214524. DOI: 10.1371/journal.pone.0206491. View

3.
Flood D, Seiglie J, Dunn M, Tschida S, Theilmann M, Marcus M . The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. Lancet Healthy Longev. 2022; 2(6):e340-e351. PMC: 8865379. DOI: 10.1016/s2666-7568(21)00089-1. View

4.
Luo D, Cheng Y, Zhang H, Ba M, Chen P, Li H . Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis. BMJ. 2020; 370:m3222. PMC: 7478061. DOI: 10.1136/bmj.m3222. View

5.
Einarson T, Acs A, Ludwig C, Panton U . Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018; 17(1):83. PMC: 5994068. DOI: 10.1186/s12933-018-0728-6. View